Finally, the pleiotropic role of syntaxin-6 across multiple neurodegenerative diseases, including PSP and AD, raises the potential that STX6-targeting therapies could have wider applicability to other neurode-generative diseases, warranting further investigation. The gene discussed is STX6; the disease is Alzheimer disease.